Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sevcikova

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Oncogene|August 16, 2006
v-Myb represses the transcription of Ets-2D-M Wang, S Sevcikova, H Wen, et al.
Disease Markers|February 28, 2019
Levels of CEACAM6 in Peripheral Blood Are Elevated in Patients with Plasma Cell Disorders: A Potential New Diagnostic Marker and a New Therapeutic Target?N Steiner, R Hajek, D Nachbaur, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 15, 2017
Liquid Biopsies - the Clinics and the MoleculesV Kubaczková, L Sedlarikova, B Bollová, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|December 18, 2019
Bortezomib and Thalidomide Treatment Results in Newly Diagnosed Transplant-Ineligible Multiple Myeloma Patients are Comparable in Long-Term Follow-UpM Stork, V Sandecká, I Boichuk, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 15, 2017
Biobanking - the First Step to Successful Liquid Biopsy ExperimentsM Almasi, S Sevcikova, M Penka, et al.
Neoplasma|June 27, 2018
Retreatment with lenalidomide is an effective option in heavily pretreated refractory multiple myeloma patientsM Stork, S Sevcikova, Z Adam, et al.
Neoplasma|June 23, 2020
Diagnostic relevance of 18F-FDG PET/CT in newly diagnosed patients with monoclonal gammopathy of undetermined significance (MGUS): Single-center experienceV Sandecka, Z Adam, M Krejci, et al.
Neoplasma|December 13, 2019
Bortezomib retreatment is effective in relapsed multiple myeloma patients - real-life clinical practice dataM Stork, S Sevcikova, L Brozova, et al.
Neoplasma|September 8, 2011
Prognostic significance of morphological assessment of plasma cells in multiple myelomaM Al-Sahmani, I Trnavska, S Sevcikova, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Oncogene|August 16, 2006
v-Myb represses the transcription of Ets-2D-M Wang, S Sevcikova, H Wen, et al.
Disease Markers|February 28, 2019
Levels of CEACAM6 in Peripheral Blood Are Elevated in Patients with Plasma Cell Disorders: A Potential New Diagnostic Marker and a New Therapeutic Target?N Steiner, R Hajek, D Nachbaur, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 15, 2017
Liquid Biopsies - the Clinics and the MoleculesV Kubaczková, L Sedlarikova, B Bollová, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|December 18, 2019
Bortezomib and Thalidomide Treatment Results in Newly Diagnosed Transplant-Ineligible Multiple Myeloma Patients are Comparable in Long-Term Follow-UpM Stork, V Sandecká, I Boichuk, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 15, 2017
Biobanking - the First Step to Successful Liquid Biopsy ExperimentsM Almasi, S Sevcikova, M Penka, et al.
Neoplasma|June 27, 2018
Retreatment with lenalidomide is an effective option in heavily pretreated refractory multiple myeloma patientsM Stork, S Sevcikova, Z Adam, et al.
Neoplasma|June 23, 2020
Diagnostic relevance of 18F-FDG PET/CT in newly diagnosed patients with monoclonal gammopathy of undetermined significance (MGUS): Single-center experienceV Sandecka, Z Adam, M Krejci, et al.
Neoplasma|December 13, 2019
Bortezomib retreatment is effective in relapsed multiple myeloma patients - real-life clinical practice dataM Stork, S Sevcikova, L Brozova, et al.
Neoplasma|September 8, 2011
Prognostic significance of morphological assessment of plasma cells in multiple myelomaM Al-Sahmani, I Trnavska, S Sevcikova, et al.
Pageof 1